What is he best known for?
The fields of study he is best known for:
Hidetoshi Arima mainly focuses on Cyclodextrin, Conjugate, Biochemistry, Pharmacology and Dendrimer.
The concepts of his Cyclodextrin study are interwoven with issues in Insulin, Biophysics, Stereochemistry and Solubility.
His Cholesterol, Efflux and Caco-2 study in the realm of Biochemistry interacts with subjects such as Multidrug resistance-associated protein 2 and P-glycoprotein.
His Pharmacology research integrates issues from Drug delivery and In vivo.
Hidetoshi Arima interconnects DNA, Transfection, Gene delivery, Cytotoxicity and Mannose in the investigation of issues within Dendrimer.
His Cytotoxicity study incorporates themes from Asialoglycoprotein receptor, Genetic transfer and Molecular biology.
His most cited work include:
- Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins (195 citations)
- Cyclodextrins in transdermal and rectal delivery. (163 citations)
- Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins (150 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cyclodextrin, Conjugate, Biochemistry, Dendrimer and Pharmacology.
The Cyclodextrin study combines topics in areas such as Combinatorial chemistry, Stereochemistry and Solubility.
The study incorporates disciplines such as Chromatography, Beta-Cyclodextrins, Stability constants of complexes and Dissolution in addition to Solubility.
His Dendrimer research incorporates themes from In vitro, Cytotoxicity, Biophysics, Transfection and Molecular biology.
His In vitro research is multidisciplinary, incorporating perspectives in Liposome and Gene delivery.
His study in the fields of Bioavailability, Pharmacokinetics and Drug carrier under the domain of Pharmacology overlaps with other disciplines such as Doxorubicin.
He most often published in these fields:
- Cyclodextrin (38.71%)
- Conjugate (16.77%)
- Biochemistry (16.77%)
What were the highlights of his more recent work (between 2017-2021)?
- Cyclodextrin (38.71%)
- Pharmacology (16.45%)
- In vivo (11.29%)
In recent papers he was focusing on the following fields of study:
Hidetoshi Arima mostly deals with Cyclodextrin, Pharmacology, In vivo, Niemann–Pick disease, type C and Endocrinology.
His Cyclodextrin study is concerned with Biochemistry in general.
The study incorporates disciplines such as Lysosomal storage disease, Lipopolysaccharide, Proinflammatory cytokine and Atopic dermatitis in addition to Pharmacology.
His In vivo research is multidisciplinary, relying on both In vitro, Moiety, Targeted drug delivery and Small interfering RNA.
His In vitro research focuses on Ternary complex and how it relates to Dendrimer, Stereochemistry and Blood chemistry.
His research integrates issues of GM1 Gangliosidosis and Internal medicine in his study of Endocrinology.
Between 2017 and 2021, his most popular works were:
- DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination. (17 citations)
- Supramolecular Pharmaceutical Sciences: A Novel Concept Combining Pharmaceutical Sciences and Supramolecular Chemistry with a Focus on Cyclodextrin-Based Supermolecules. (14 citations)
- Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer. (10 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Cyclodextrin, Pharmacology, Cholesterol, Supramolecular chemistry and Cytotoxic T cell.
His Cyclodextrin research incorporates themes from Combinatorial chemistry and Stability constants of complexes.
The concepts of his Pharmacology study are interwoven with issues in Lipopolysaccharide, Chemokine, Proinflammatory cytokine, Immunoglobulin E and In vivo.
His studies in Supramolecular chemistry integrate themes in fields like Copolymer, Nanotechnology, Pharmaceutical sciences, Polyrotaxane and Active ingredient.
His Cytotoxic T cell study also includes fields such as
- Adamantane that connect with fields like Cancer cell, Cancer research and Ligand,
- Colorectal cancer together with Folate receptor.
Hidetoshi Arima focuses mostly in the field of Folate receptor, narrowing it down to topics relating to In vitro and, in certain cases, Dendrimer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
